Nanoscience is an interdisciplinary subject. The course in Nanoscience & Technology deals with knowledge which play an important role in everyday life. Nanoscience is one of the driving forces behind the development of new technologies in Energy, Environment, Medicine & Health, Bioengineering & Biotechnology, Food, Cosmetics & Pharmaceutical industries.
The programme focuses on how to manipulate nanostructures and material structures and how to develop new functionalities in the areas of Medicine (Regenerative Medicine), Food Science, Cosmetics, Environment (renewable energy), Nano-biotechnology. As a student you will gain a broader understanding of fundamental theories and learn to handle concepts and methods used in the field of nanoscience and technology
A graduate in Science (B.Sc.) from an UGC recognized University with Physics, Chemistry or Biology as a major or other science
As of now, MSc Nanoscience students are placed as
MSc Nanoscience students can get job as
Indian Students : INR 46200.00 per year
For NRI students : USD 1320 per year
Dr. Srinivasan is a translational biomedical an a formulation scientist with a distinguished academic and research career spanning the United Kingdom, Germany, the United States, and India. She holds an MSc in Biomedical Sciences and a PhD from the University of Bradford, UK, where she was awarded the University of Bradford International Scholarship for her master's degree and a National Health Service (NHS) Fellowship for her doctoral research. Her PhD focused on identifying clinical biomarkers for patients with liver and pancreatic diseases and cancer.
Prior to her postdoctoral training, Dr. Srinivasan gained research experience at the Max Planck Institute, Germany, investigating the role of Protein Kinase C (PKC) in cancer biology. She subsequently joined Thomas Jefferson University, Philadelphia, USA, as a postdoctoral researcher, where she conducted extensive work in cancer nanomedicine and the formulation of nanoparticles for targeted drug delivery — with a particular focus on lung and breast cancer. A highlight of this period was her pioneering research on delivering nano-sized monoclonal antibodies as nanoparticles targeting non-small cell lung cancer cell lines, validated in nude mouse models. This work resulted in a patent filing and earned her the prestigious American Association of Pharmaceutical Sciences (AAPS) Innovation in Biotechnology Award (May 2013), sponsored by Genentech, at the National Biotechnology Conference in San Diego, California.
As an independent researcher, Dr. Srinivasan's work is driven by a commitment to translating scientific discovery into real-world impact. Her research-to-commercialization model encompasses lab developed/ fabricated biomedical product development, targeted drug delivery formulations, pre-clinical screening and toxicology assessment, and pilot-phase clinical trials — reflecting her evolution from biomedical science graduate to full-spectrum translational scientist.
She has successfully secured competitive research funding from several prestigious bodies, including DBT-BIRAC-PACE, BIRAC-BIG, and Nidhi Prayas, in addition to industry consultancy projects. She has established spin-off companies to advance the commercial translation of her research. In recognition of her scientific standing, she was selected as a Scientific High-Level Visiting Fellow through the French Institute in India program, enabling collaborative research at a leading public institute in France. She is also a Fellow of the Indian National Science Academy (INSA). Dr. Srinivasan's career exemplifies the bridge between fundamental biomedical research and its practical application for patient benefit.